AstraZeneca PLC (AZN)
156.90
-0.80
(-0.51%)
USD |
NYSE |
Oct 02, 16:00
157.01
+0.11
(+0.07%)
After-Hours: 20:00
AstraZeneca Gross Profit Margin (Quarterly) : 76.09% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 76.09% |
| December 31, 2025 | 72.19% |
| September 30, 2025 | 73.89% |
| June 30, 2025 | 75.17% |
| March 31, 2025 | 76.45% |
| December 31, 2024 | 67.73% |
| September 30, 2024 | 71.08% |
| June 30, 2024 | 75.69% |
| March 31, 2024 | 75.21% |
| December 31, 2023 | 72.60% |
| September 30, 2023 | 73.15% |
| June 30, 2023 | 74.19% |
| March 31, 2023 | 72.02% |
| December 31, 2022 | 64.88% |
| September 30, 2022 | 63.91% |
| June 30, 2022 | 62.62% |
| March 31, 2022 | 60.59% |
| December 31, 2021 | 51.88% |
| September 30, 2021 | 50.97% |
| June 30, 2021 | 68.64% |
| March 31, 2021 | 72.59% |
| December 31, 2020 | 75.35% |
| September 30, 2020 | 79.83% |
| June 30, 2020 | 84.70% |
| March 31, 2020 | 79.10% |
| Date | Value |
|---|---|
| December 31, 2019 | 60.82% |
| September 30, 2019 | 80.73% |
| June 30, 2019 | 81.99% |
| March 31, 2019 | 81.83% |
| December 31, 2018 | 70.85% |
| September 30, 2018 | 80.24% |
| June 30, 2018 | 82.59% |
| March 31, 2018 | 78.72% |
| December 31, 2017 | 79.71% |
| September 30, 2017 | 80.71% |
| June 30, 2017 | 82.04% |
| March 31, 2017 | 84.16% |
| December 31, 2016 | 80.00% |
| September 30, 2016 | 85.24% |
| June 30, 2016 | 81.38% |
| March 31, 2016 | 83.73% |
| December 31, 2015 | 80.70% |
| September 30, 2015 | 82.88% |
| June 30, 2015 | 84.00% |
| March 31, 2015 | 79.76% |
| December 31, 2014 | 75.70% |
| September 30, 2014 | 79.32% |
| June 30, 2014 | 80.86% |
| March 31, 2014 | 77.68% |
| December 31, 2013 | 60.24% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| GSK Plc | 75.05% |
| Johnson & Johnson | 68.73% |
| Eli Lilly & Co. | 85.78% |
| Merck & Co., Inc. | 71.51% |
| Novo Nordisk A/S | 78.21% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 22.80% |
| Return on Assets | 9.26% |
| Return on Invested Capital | 13.38% |
| Profit Margin (Quarterly) | 20.15% |
| Operating Margin (Quarterly) | 26.93% |
| Return on Net Operating Assets | 11.21% |